Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Anika Therapeutics Inc. (ANIK) vs Cardiol Therapeutics Inc. (CRDL)

Anika Therapeutics Inc. and Cardiol Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $270.7M against $202.1M — 1.3× the size. Cardiol Therapeutics Inc. has the higher net margin (0.00% vs −3.14%) and the higher return on invested capital (0.00% vs −3.24%). Across the 14 metrics below, Anika Therapeutics Inc. leads on 9 and Cardiol Therapeutics Inc. on 5.

Valuation

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 2.25 n/m 2.25
P/B 1.98 11.32 1.90
Price to free cash flow 483.15 n/m 16.54
EV/EBITDA 508.54 n/m 12.29
EV/Sales 2.16 n/m 2.56
Earnings yield (1.28%) (14.62%) (2.99%)
Free cash flow yield 0.21% (8.77%) 0.00%

Profitability

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 0.00% 53.94%
Operating margin (4.24%) 0.00% 0.00%
Net margin (3.14%) 0.00% 0.00%
Free cash flow margin 0.47% 0.00% 0.00%
Return on equity (2.66%) (171.13%) (0.40%)
Return on assets (2.04%) (124.40%) (3.32%)
Return on invested capital (3.24%) 0.00% 0.00%

Growth

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% — 10.01%
EPS growth (last fiscal year) 80.16% 24.32% —
Revenue growth, 5-year CAGR (2.86%) — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 4.48 5.55 2.31
Net debt to EBITDA 10.80 0.62 0.85

Dividend

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ANIK CRDL Drug Manufacturers Specialty & Generic median
Market cap 270.74m 202.10m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack